• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Depleting CAR T cells after tumor treatment reverses B cell deficiency in mice

Bioengineer by Bioengineer
October 17, 2016
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Genetically engineered T cells, or CAR T cells, represent a promising approach to treat multiple types of cancer.

mice 7

These therapies can eliminate tumors by targeting specific markers that are expressed on different cancer cell types. CAR T cell treatments for B cell-associated cancers have been particularly successful in eradicating tumors. These treatments destroy tumor cells expressing CD19, a protein that is upregulated at the early stages of B cell development. Unfortunately, because CAR T cells persist after a patient goes into remission, continual targeting of CD19 can lead to long-term depletion of healthy B cells.

In this issue of the JCI, a team led by Dirk Busch at Technical University München has developed a strategy to prevent depletion of healthy B cells after successful CAR T cell treatments for B cell lymphomas. They created CD19-targeting CAR T cells that also express a non-functional form of another protein called EGFR. They then treated a mouse model of leukemia with the EGFR- and CD19-targeting T cells. After the treatment successfully eliminated B cell tumors in these mice, the researchers administered an antibody for EGFR, which depleted CAR T cells. This strategy permanently restored levels of healthy B cells without causing cancer relapse in the mouse model. This work provides evidence that incorporating an additional targeting mechanism into genetically engineered cells may improve the safety of these cell-based therapies.

###

TITLE:

Targeted antibody-mediated depletion of CD19 CAR-T cells permanently reverses B cell aplasia

AUTHOR CONTACT:

Dirk Busch
Technical University München
[email protected]

View this article at: http://www.jci.org/articles/view/84813?key=fed9e949b703c563bf23

Media Contact

Elyse Dankoski
[email protected]
@jclinicalinvest

http://www.jci.org

The post Depleting CAR T cells after tumor treatment reverses B cell deficiency in mice appeared first on Scienmag.

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Valencene Guards Against Benzo(a)pyrene Lung Cancer

August 5, 2025
blank

Impact of State-Level Insurance Expansion on Racial Disparities in Breast Density-Based Screening Eligibility

August 5, 2025

Comparing Pre-Surgery Therapies for Esophageal Cancer

August 5, 2025

TIGIT: Emerging Immune Checkpoint Target in Breast Cancer

August 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Neuropsychiatric Risks Linked to COVID-19 Revealed

    72 shares
    Share 29 Tweet 18
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    46 shares
    Share 18 Tweet 12
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Stability and Refolding of Zika Virus EDIII Protein

Assessing Demirjian Method Reliability Among Forensic Experts

Malaria Rapid Test Accuracy in Young Burkina Faso Children

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.